Finepoint Capital LP Diversified Active

CIK: 0001608126 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 12, 2023

Total Value ($000): $261,803 (100.0% shares, 0.0% debt)

Holdings (38)

TVTX TRAVERE THERAPEUTICS INC 7.5%
Value ($000) $19,684 Shares 875,221 Est. Cost $25.45 Unrealized -16.5%
APLS APELLIS PHARMACEUTICALS INC 7.1%
Value ($000) $18,712 Shares 283,690 Est. Cost $47.12 Unrealized +22.4%
IVERIC BIO INC 6.7%
Value ($000) $17,605 Shares 723,600 Est. Cost $9.95 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 6.6%
Value ($000) $17,246 Shares 916,353 Est. Cost $17.65 Unrealized +7.9%
GLPG GALAPAGOS NV 6.6%
Value ($000) $17,182 Shares 444,659 Est. Cost $48.81 Unrealized
SRPT SAREPTA THERAPEUTICS INC 6.5%
Value ($000) $16,920 Shares 122,757 Est. Cost $115.88 Unrealized +11.9%
ASND ASCENDIS PHARMA A/S 6.4%
Value ($000) $16,734 Shares 156,072 Est. Cost $88.65 Unrealized
SAGE THERAPEUTICS INC 6.2%
Value ($000) $16,317 Shares 388,865 Est. Cost $32.48 Unrealized
FOLD AMICUS THERAPEUTICS INC 6.2%
Value ($000) $16,193 Shares 1,460,175 Est. Cost $8.32 Unrealized +48.1%
PRTA PROTHENA CORP PLC 6.1%
Value ($000) $16,073 Shares 331,600 Est. Cost $31.42 Unrealized +68.1%
SPRINGWORKS THERAPEUTICS INC 6.0%
Value ($000) $15,810 Shares 614,231 Est. Cost $13.68 Unrealized
CYTK CYTOKINETICS INC 5.6%
Value ($000) $14,561 Shares 413,793 Est. Cost $40.42 Unrealized +0.9%
CRNX CRINETICS PHARMACEUTICALS IN 5.3%
Value ($000) $13,947 Shares 868,427 Est. Cost $17.67 Unrealized +4.7%
RLAY RELAY THERAPEUTICS INC 5.3%
Value ($000) $13,938 Shares 846,270 Est. Cost $18.95 Unrealized -5.4%
ARVN ARVINAS INC 5.1%
Value ($000) $13,450 Shares 492,300 Est. Cost $45.99 Unrealized -31.3%
CEREVEL THERAPEUTICS HLDNG I 5.0%
Value ($000) $13,157 Shares 539,445 Est. Cost $28.10 Unrealized
SLDB SOLID BIOSCIENCES INC 0.9%
Value ($000) $2,317 Shares 488,857 Est. Cost $6.25 Unrealized -3.9%
ARES ACQUISITION CORP 0.2%
Value ($000) $444 Shares 504,706 Est. Cost $0.85 Unrealized
HOME PLATE ACQUISITION CORP 0.1%
Value ($000) $219 Shares 690,000 Est. Cost $0.60 Unrealized
BRIDGETOWN HOLDINGS LTD 0.1%
Value ($000) $134 Shares 895,000 Est. Cost $1.24 Unrealized
ROSS ACQUISITION CORP II 0.0%
Value ($000) $115 Shares 439,666 Est. Cost $0.89 Unrealized
CONYERS PARK III ACQUISITION CORP 0.0%
Value ($000) $114 Shares 571,666 Est. Cost $1.04 Unrealized
CHURCHILL CAPITAL CORP V 0.0%
Value ($000) $114 Shares 612,000 Est. Cost $1.30 Unrealized
MARBLEGATE ACQUISITION CORP 0.0%
Value ($000) $110 Shares 735,000 Est. Cost $0.50 Unrealized
LSBWF YS BIOPHARMA CO LTD 0.0%
Value ($000) $76 Shares 489,999 Est. Cost $0.16 Unrealized
CHURCHILL CAPITAL CORP VII 0.0%
Value ($000) $67 Shares 548,000 Est. Cost $0.92 Unrealized
AFTERNEXT HEALTHTECH ACQUISITION CORP 0.0%
Value ($000) $61 Shares 366,666 Est. Cost $0.70 Unrealized
ZIMMER ENERGY TRANSITION ACQUISITION CORP 0.0%
Value ($000) $60 Shares 358,270 Est. Cost $1.34 Unrealized
JAWS HURRICANE ACQUISITION CORP 0.0%
Value ($000) $60 Shares 387,249 Est. Cost $1.15 Unrealized
IVCPW SWIFTMERGE ACQUISITION CORP 0.0%
Value ($000) $60 Shares 490,000 Est. Cost $0.21 Unrealized
CDAWF COMPASS DIGITAL ACQUISITION CORP 0.0%
Value ($000) $60 Shares 459,906 Est. Cost $0.76 Unrealized
CHURCHILL CAPITAL CORP VI 0.0%
Value ($000) $59 Shares 540,000 Est. Cost $1.20 Unrealized
CORSAIR PARTNERING CORP 0.0%
Value ($000) $54 Shares 334,666 Est. Cost $0.76 Unrealized
SENIOR CONNECT ACQUISITION COR 0.0%
Value ($000) $51 Shares 1,014,000 Est. Cost $0.71 Unrealized
CNDAW CONCORD ACQUISITION CORP II 0.0%
Value ($000) $29 Shares 408,333 Est. Cost $0.95 Unrealized
CLDWW FIRST LIGHT ACQUISITION GROUP INC 0.0%
Value ($000) $27 Shares 655,200 Est. Cost $0.50 Unrealized
BILANDER ACQUISITION CORP 0.0%
Value ($000) $24 Shares 183,749 Est. Cost $1.10 Unrealized
SKYDECK ACQUISITION CORP 0.0%
Value ($000) $18 Shares 361,756 Est. Cost $0.75 Unrealized